General

Cell Therapy Maker Legend Biotech Is An 'Attractive Opportunity' Due To No Material Tariff Exposure: Analyst
Johnson & Johnson's New 'Compelling Data' Shows Sustained Symptom Improvement In Muscular Disease Patients
Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients
Johnson & Johnson's New 'Compelling Data' Shows Sustained Symptom Improvement In Muscular Disease Patients
Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients
Trump Tariff Strategy Creates 'Self-Inflicted Market Debacle': Analyst
Amazon And Google Backed Anthropic Plans Major EU Hiring Drive, Names New EMEA Chief

General Recent News

Elizabeth Warren Says Congress Has 'Power To Pull Our Economy Back' From The Brink As Don Bacon Moves To Limit Trump's Tariff Power: 'Need A Handful Of Republicans Not To Bend A Knee'
Elizabeth Warren urged Congress—particularly a few Republicans—to resist Trump's influence and act swiftly to prevent economic turmoil, warning of a repeat of the 2008 crisis.
Tariffs, Recession Fears Could Derail Wayfair, RH And Etsy, Says Analyst
BofA warns 2025 tariffs could severely impact U.S. home furnishing retailers like Wayfair (NYSE: W) and RH (NYSE: RH), with potential price hikes up to 30% due to sourcing from Asia. Rising costs, weak demand, and recession fears may further hurt sales.
Cartesian Therapeutics Reports Strong 12-Month Data For Lead Cell Therapy In Myasthenia Gravis Patients
Cartesian reports 12-month data for Descartes-08 in myasthenia gravis; Phase 3 AURORA trial expected to begin in Q2 2025.
UPS Expands Delivery Options With Two New Ground Services
Aimed at both consumers and businesses, the new services offer reliable shipping with cost-effective flexibility.
Medicare Advantage Rates Expected To Climb Over 5% In 2026, Easing Pressure On Managed Care
CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care.
Intuitive Machines Taps SpaceX For 2027 Lunar Mission, Stock Gains
Intuitive Machines Inc. (NASDAQ: LUNR) is gaining ground after announcing its fourth lunar mission, IM-4, will launch aboard a SpaceX Falcon 9 rocket in 2027. The mission supports NASA's Near Space Network Services and aims to enhance Moon-based communications with new relay satellites.
Tilray Brands Reports Lower Cannabis Sales In Q3, Trims 2025 Revenue Outlook
Tilray Brands missed Q3 revenue expectations and lowered FY25 outlook, while beverage and wellness units posted year-over-year revenue increases.
What's Going On With Rocket Lab Stock Today?
Rocket Lab USA Inc.
Walgreens Boots Alliance Q2 Profit Falls 47.5%, Suspends Guidance On Pending Private Equity Deal
Walgreens reports Q2 revenue beat with strong pharmacy growth, but earnings fall amid weaker retail sales and U.S. Healthcare shifts.
Elon Musk's Secretive DOGE Team Using AI And Disappearing Messages To Monitor Federal Workers For Anti-Trump Sentiment, Bypassing Records Laws And Locking Out Agencies: Report
DOGE is reportedly spying on federal workers using AI tools.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved